5DX Meta Health
- 0.009
- +0.001+12.50%
Meta Health News
Law Ren Kai Takes Helm as Meta Health Chairman
Meta Health Appoints Board Chairman
Meta Health (SGX:5DX) appointed Kenneth Law as chairman of the board, effective Monday, a Singapore bourse filing on Tuesday showed. Law succeeds Bernard Ng, who stepped down to separate the roles of
Meta Health Appoints Tembusu Partners CFO as Chairman of the Board
Meta Health Appoints Acting Head of Finance
Meta Health (SGX:5DX) appointed Cheah You Kong as the company's acting head of finance and executive officer, effective May 1, according to a filing with the Singapore Exchange on Thursday. Kong curre
Meta Health CFO Transition Ahead of Schedule
Meta Health's CFO Resigns
Tan Sze Leng, the chief financial officer (SGX:5DX) of Meta Health (SGX:5DX), has resigned in order to "pursue other opportunities," a bourse disclosure revealed on late Monday. Leng is serving a thre
Meta Health Full Year 2023 Earnings: S$0.004 Loss per Share (Vs S$0.016 Loss in FY 2022)
Meta Health Marginally Trims Attributable Loss for H2 2023; Revenue Plunges 61%
Meta Health (SGX:5DX) posted a slight improvement on its attributable loss to owners for the second half of 2023, down 2% to nearly SG$6.0 million, compared with SG$5.9 million in the year-ago period.
Meta Health Completes Sale of China Units
Healthcare technology company Meta Health (SGX:5DX) subsidiary, MCE Holdings, has completed the sale of its subsidiary MCE Technologies (Suzhou) and its arm, MCE Shanghai, to Jiangsu TNS Industry Scie
Meta Health Subsidiary Working With Buyer to Complete Sale of China-based Unit
Meta Health's (SGX:5DX) subsidiary, MCE Holdings, is working with Jiangsu TNS Industry Science & Technology, the buyer of MCE Technologies (Suzhou), to complete the registration process required under
Meta Health Reaches Out-of-Court Settlement With Subsidiary's Former Executives
Meta Health (SGX:5DX) reached an out-of-court settlement with Vasanthan Metupalle, the former chief medical officer of Meta subsidiary 5Digital, and Jagannathan Padmaja Sakthi, a former director of Me
Meta Health to Sell China Units to Jiangsu TNS Industry Science & Technology for 17 Million Yuan
Meta Health's (SGX:5DX) MCE Technologies Holdings subsidiary agreed to sell its MCE Technologies (Suzhou) unit to Jiangsu TNS Industry Science & Technology for an equity consideration of 17.2 million
Loss-making Meta Health (Catalist:5DX) Sheds a Further S$543k, Taking Total Shareholder Losses to 67% Over 1 Year
Meta Health Disposing of Units in Malaysia, Thailand; Shares Climb 11%
Meta Health (SGX:5DX) agreed to dispose of 100% of its wholly owned subsidiaries, MCE Technologies and MCT Thailand, to a special purpose vehicle to be incorporated by UWC, Boon Che Kwang, and Tan Yoo
Meta Health Updates on Intended Use of Proceeds From Proposed Rights Issue
Meta Health (SGX:5DX) said it expects to raise about SG$2.6 million in net proceeds from its recently proposed renounceable non-underwritten rights issue of up to 518,066,109 ordinary shares at SG$0.0
Meta Health Proposes Renounceable Non-Underwritten Rights Issue; Shares Fall 23%
Meta Health (SGX:5DX) proposed to carryout a renounceable non-underwritten rights issue of up to 518,066,109 ordinary shares at SG$0.0055 apiece. The company will issue nine rights shares for every 10
Meta Health Trims Losses in H1
Meta Health's (SGX:5DX) loss attributable to equity holders narrowed to SG$2.1 million, or SG$0.0039 per share, in the first half, from SG$2.8 million, or SG$0.0053 per share, a year ago. Earnings per
Meta Health to Dispose of Units in Malaysia, Thailand
Meta Health (SGX:5DX) signed a non-binding term sheet to dispose of 100% of its wholly owned subsidiaries, MCE Technologies and MCT Thailand, to a special purpose vehicle to be incorporated by UWC, Bo
Meta Health Commences Legal Proceedings Against Ex-chief Medical Officer of Subsidiary
HEALTHCARE technology company Meta Health has commenced legal proceedings in the High Court of Singapore against Vasanthan Metupalle, the former chief medical...
Meta Health Limited (Catalist:5DX) May Have Run Too Fast Too Soon With Recent 38% Price Plummet
Analysis
Price Target
No Data
